Clinical trial
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus…
NCT00421720 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00421720 |
|---|---|
| Title | A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. |
| Official title | A Randomized, Open-label, Multicenter, Parallel-group Study to Compare the Efficacy, Safety and Resource Utilization of a Remifentanil/Propofol Analgesia/Sedation Regimen Versus a Sufentanil/Propofol Analgesia/Sedation Regimen in Mechanically Ventilated Intensive Care Patients Requiring Analgesia… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Analgesia, Sedation |
| Intervention type | Drug |
| Interventions | Sufentanil, Remifentanil |
| Enrollment | 164 |
| Start date | Jan 1, 2007 |
| First posted | Jan 12, 2007 |
| Last update posted | Apr 3, 2018 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: